134 Grants (Page 3 of 6)
2000
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S4-0620), 12/01/1999 -- 11/30/2000
 
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S5-0620), 12/01/1999 -- 11/30/2000
 
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S2-0620), 12/01/1999 -- 11/30/2000
 
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S3-0620), 12/01/1999 -- 11/30/2000
 
RANDOMIZED DOUBLE BLIND STUDY OF THE ANTIVIRAL ACTIVITY OF DIDANOSINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-28-0620), 12/01/1999 -- 11/30/2000
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S3-0630), 12/01/1999 -- 11/30/2000
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-28-0630), 12/01/1999 -- 11/30/2000
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S4-0630), 12/01/1999 -- 11/30/2000
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S5-0630), 12/01/1999 -- 11/30/2000
 
VIROLOGIC AND IMMUNOLOGIC ACTIVITY OF CONTINUED LAMIVUDINE VERSUS DELAVIRDINE
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S2-0630), 12/01/1999 -- 11/30/2000
1999
ANTIVIRAL ACTIVITY AND RESISTANCE OF LAMIVUDINE IN COMBINATION WITH DDI OR D4T
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0533), 12/01/1998 -- 11/30/1999
 
ANTIVIRAL ACTIVITY AND RESISTANCE OF LAMIVUDINE IN COMBINATION WITH DDI OR D4T
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0533), 12/01/1998 -- 11/30/1999
 
COMPARISON OF THE VIROLOGIC EFFICACY OF NULFINAVIR/DMP 266 IN COMBINATION
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0628), 12/01/1998 -- 11/30/1999
 
COMPARISON OF THE VIROLOGIC EFFICACY OF NULFINAVIR/DMP 266 IN COMBINATION
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0628), 12/01/1998 -- 11/30/1999
 
COMPARISON OF THE VIROLOGIC EFFICACY OF NULFINAVIR/DMP 266 IN COMBINATION
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0628), 12/01/1998 -- 11/30/1999
 
D4T VS ZDV PLUS D4T VS ZDV PLUS DDI IN HIV INFECTED PATIENTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0509), 12/01/1998 -- 11/30/1999
 
D4T VS ZDV PLUS D4T VS ZDV PLUS DDI IN HIV INFECTED PATIENTS
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0509), 12/01/1998 -- 11/30/1999
 
INFLUENCE OF RISK FOR DISEASE PROGRESSION ON RESPONSE TO ANTIRETROVIRAL THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0529), 12/01/1998 -- 11/30/1999
 
INFLUENCE OF RISK FOR DISEASE PROGRESSION ON RESPONSE TO ANTIRETROVIRAL THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0529), 12/01/1998 -- 11/30/1999
 
ISIS 2105 W/ VEHICLE CONTROL FOR SURGICAL ADJUNCTIVE THERAPY/CONDYLOM
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0643), 12/01/1998 -- 11/30/1999
 
NUCLEOSIDE THERAPY FOR ADVANCED HIV DISEASE WITH PRIOR NUCLEOSIDE THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0396), 12/01/1998 -- 11/30/1999
 
NUCLEOSIDE THERAPY FOR ADVANCED HIV DISEASE WITH PRIOR NUCLEOSIDE THERAPY
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0396), 12/01/1998 -- 11/30/1999
 
OPEN LABEL TREATMENT OF HIV INFECTED SUBJECT WITH TIMUNOX
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-27-0527), 12/01/1998 -- 11/30/1999
 
OPEN LABEL TREATMENT OF HIV INFECTED SUBJECT WITH TIMUNOX
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S1-0527), 12/01/1998 -- 11/30/1999
 
ORAL ISOTRETINOIN VS OBSERVATION FOR LOW GRADE CERVICAL DYSPLASIA IN
Fife, Kenneth H
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-27S3-0645), 12/01/1998 -- 11/30/1999